This page in English
Laddar profil information

Publikationer

Clinic continuity of care, clinical outcomes and direct costs for COPD in Sweden: a population based cohort study
Sveréus S, Larsson K, Rehnberg C
European clinical respiratory journal 2017;4(1):1290193-

Direct and indirect costs for adverse drug events identified in medical records across care levels, and their distribution among payers
Natanaelsson J, Hakkarainen Km, Hägg S, Andersson Sundell K, Petzold M, Rehnberg C, et al
Research in social & administrative pharmacy : RSAP 2017;13(6):1151-1158

Linking Swedish health data registers to establish a research database and a shared decision-making tool in hip replacement
Cnudde P, Rolfson O, Nemes S, Kärrholm J, Rehnberg C, Rogmark C, et al
BMC musculoskeletal disorders 2016;17(1):414-

A Window on Geographic Variation in Health Care: Insights from EuroHOPE
Heijink R, Engelfriet P, Rehnberg C, Kittelsen Sa, Häkkinen U, Eurohope Study Group
Health economics 2015;24 Suppl 2():164-77

Coordination pays off: a comparison of two models for organizing hip fracture care, outcomes and costs
Löfgren S, Rehnberg C, Ljunggren G, Brommels M
The International journal of health planning and management 2015;30(4):426-38

Costs and Quality at the Hospital Level in the Nordic Countries
Kittelsen Sa, Anthun Ks, Goude F, Huitfeldt Im, Häkkinen U, Kruse M, et al
Health economics 2015;24 Suppl 2():140-63

Decomposing the productivity differences between hospitals in the Nordic countries
Kittelsen Sac, Winsnes Ba, Anthun Ks, Goude F, Hope O, Hakkinen U, et al
JOURNAL OF PRODUCTIVITY ANALYSIS 2015;43(3):281-293

Outcome, Use of Resources and Their Relationship in the Treatment of AMI, Stroke and Hip Fracture at European Hospitals
Häkkinen U, Rosenqvist G, Iversen T, Rehnberg C, Seppälä Tt, Eurohope Study Group
Health economics 2015;24 Suppl 2():116-39

Towards Explaining International Differences in Health Care Performance: Results of the EuroHOPE Project
Häkkinen U, Iversen T, Peltola M, Rehnberg C, Seppälä Tt, Eurohope Study Group
Health economics 2015;24 Suppl 2():1-4

Cross-country comparisons of health-care costs: the case of cancer treatment in the Nordic countries
Kalseth J, Halvorsen T, Kalseth B, Sarheim Anthun K, Peltola M, Kautiainen K, et al
Health policy (Amsterdam, Netherlands) 2014;115(2-3):172-9

Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adults
Gyllensten H, Hakkarainen Km, Hägg S, Carlsten A, Petzold M, Rehnberg C, et al
PloS one 2014;9(3):e92061-

Income related inequalities in New Cooperative Medical Scheme: a five-year empirical study of Junan County in China
Yuan S, Rehnberg C, Sun X, Liu X, Meng Q
International journal for equity in health 2014;13():38-

Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey
Gyllensten H, Rehnberg C, Jönsson Ak, Petzold M, Carlsten A, Andersson Sundell K
BMJ open 2013;3(6):-

Health care performance comparison using a disease-based approach: the EuroHOPE project
Häkkinen U, Iversen T, Peltola M, Seppälä Tt, Malmivaara A, Belicza É, et al
Health policy (Amsterdam, Netherlands) 2013;112(1-2):100-9

International hospital productivity comparison: experiences from the Nordic countries
Medin E, Häkkinen U, Linna M, Anthun Ks, Kittelsen Sa, Rehnberg C, et al
Health policy (Amsterdam, Netherlands) 2013;112(1-2):80-7

How are the Costs of Drug-Related Morbidity Measured? A Systematic Literature Review
Gyllensten H, Jonsson Ak, Rehnberg C, Carlsten A
DRUG SAFETY 2012;35(3):207-19

Lifetime productivity losses associated with obesity status in early adulthood: a population-based study of Swedish men
Neovius K, Rehnberg C, Rasmussen F, Neovius M
Applied health economics and health policy 2012;10(5):309-17

Modelling drug-related morbidity in Sweden using an expert panel of pharmacists'
Gyllensten H, Hakkarainen Km, Jönsson Ak, Andersson Sundell K, Hägg S, Rehnberg C, et al
International journal of clinical pharmacy 2012;34(4):538-46

Cost efficiency of university hospitals in the Nordic countries: a cross-country analysis
Medin E, Anthun Ks, Hakkinen U, Kittelsen Sac, Linna M, Magnussen J, et al
EUROPEAN JOURNAL OF HEALTH ECONOMICS 2011;12(6):509-19

Provider performance in treating poor patients - factors influencing prescribing practices in lao PDR: a cross-sectional study
Syhakhang L, Soukaloun D, Tomson G, Petzold M, Rehnberg C, Wahlstrom R
BMC HEALTH SERVICES RESEARCH 2011;:3-

Unnecessary use of antibiotics for inpatient children with pneumonia in two counties of rural China
Liang Xy, Jin Cg, Wang L, Wei L, Tomson G, Rehnberg C, et al
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 2011;33(5):750-4

Calculation of Costs of Pregnancy-and Puerperium-related Care: Experience from a Hospital in a Low-income Country
Sarowar Mg, Medin E, Gazi R, Koehlmoos Tp, Rehnberg C, Saifi R, et al
JOURNAL OF HEALTH POPULATION AND NUTRITION 2010;28(3):264-72

Measuring cost efficiency in the Nordic Hospitals-a cross-sectional comparison of public hospitals in 2002
Linna M, Hakkinen U, Peltola M, Magnussen J, Anthun Ks, Kittelsen S, et al
HEALTH CARE MANAGEMENT SCIENCE 2010;13(4):346-57

Regional variation and adherence to guidelines for drug treatment of asthma
Arnlind Mh, Wettermark B, Nokela M, Hjemdahl P, Rehnberg C, Jonsson Ew
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2010;66(2):187-98

THE ECONOMIC BURDEN OF PSYCHIATRIC DISORDERS IN SWEDEN
Tiainen A, Rehnberg C
INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY 2010;56(5):515-26

A cost-effectiveness analysis of a community-based diabetes prevention program in Sweden
Johansson P, Ostenson Cg, Hilding A, Andersson C, Rehnberg C, Tillgren P
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 2009;25(3):350-8

How are individual-level social capital and poverty associated with health equity? A study from two Chinese cities
Sun Xj, Rehnberg C, Meng Qy
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH 2009;:2-

Methodological challenges in evaluating health care financing equity in data-poor contexts: lessons from Ghana, South Africa and Tanzania
Borghi J, Ataguba J, Mtei G, Akazili J, Meheus F, Rehnberg C, et al
Advances in health economics and health services research 2009;21():133-56

Participation, resource mobilization and financial incentives in community-based health promotion: an economic evaluation perspective from Sweden
Johansson Pm, Eriksson Ls, Sadigh S, Rehnberg C, Tillgren Pe
HEALTH PROMOTION INTERNATIONAL 2009;24(2):177-84

Perceived job security and sickness absence: a study on moral hazard
Khan J, Rehnberg C
EUROPEAN JOURNAL OF HEALTH ECONOMICS 2009;10(4):421-8

Statistical modelling needed to find the effects from a community-based elderly safety promotion program
Johansson Pm, De Leon Ap, Sadigh S, Tillgren Pe, Rehnberg C
EUROPEAN JOURNAL OF PUBLIC HEALTH 2009;19(1):100-5

Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer
Lidgren M, Jonsson B, Rehnberg C, Willking N, Bergh J
ANNALS OF ONCOLOGY 2008;19(3):487-95

Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer
Lidgren M, Wilking N, Jonsson B, Rehnberg C
ACTA ONCOLOGICA 2008;47(6):1018-28

Non-pharmaceutical prevention of hip fractures - a cost-effectiveness analysis of a community-based elderly safety promotion program in Sweden
Johansson P, Sadigh S, Tillgren P, Rehnberg C
Cost effectiveness and resource allocation : C/E 2008;6():11-

Regional variations and determinants of direct psychiatric costs in Sweden
Tiainen A, Edman G, Flyckt L, Tomson G, Rehnberg C
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH 2008;36(5):483-92

Deteriorating health status in Stockholm 1998-2002: results from repeated population surveys using the EQ-5D
Burstrom K, Johannesson M, Rehnberg C
QUALITY OF LIFE RESEARCH 2007;16(9):1547-53

Health related quality of life in different states of breast cancer
Lidgren M, Wilking N, Jonsson B, Rehnberg C
QUALITY OF LIFE RESEARCH 2007;16(6):1073-81

Resource use and costs associated with different states of breast cancer
Lidgren M, Wilking N, Jonsson B, Rehnberg C
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 2007;23(2):223-31

At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis
Borgstrom F, Johnell O, Kanis Ja, Jonsson B, Rehnberg C
OSTEOPOROSIS INTERNATIONAL 2006;17(10):1459-71

Cost of depression in Europe
Sobocki P, Jonsson B, Angst J, Rehnberg C
JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS 2006;9(2):87-98

Costs and quality of life associated with osteoporosis-related fractures in Sweden
Borgstrom F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, et al
OSTEOPOROSIS INTERNATIONAL 2006;17(5):637-50

Health related quality of life in different states of breast cancer
Lidgren M, Wilking N, Jonsson B, Rehnberg C
VALUE IN HEALTH 2006;9(6):A195-A195

Model to assess the cost-effectiveness of new treatments for depression
Sobocki P, Ekman M, Agren H, Jonsson B, Rehnberg C
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 2006;22(4):469-77

The costs and benefits of regulations for reimbursement of new drugs
Lundkvist J, Jonsson B, Rehnberg C
HEALTH POLICY 2006;79(2-3):337-44

The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care
Arnlind Mh, Nokela M, Rehnberg C, Jonsson Ew
JOURNAL OF ASTHMA 2006;43(8):585-91

Cost-effectiveness of new drugs: A systematic review of published evidence for new chemical entity drugs introduced on the Swedish market 1987-2000
Lundkvist J, Jonsson B, Rehnberg C
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 2005;21(2):187-93

[Drug committees should be abolished because the reality has changed]
Jönsson B, Arvidsson G, Levin La, Rehnberg C
Lakartidningen 2005;102(11):880-1

[Drug utilization decisions should be based on cost-benefit data]
Bengt J, Arvidsson G, Levin La, Rehnberg C
Lakartidningen 2005;102(16):1264-5

The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey
Masiye F, Rehnberg C
MALARIA JOURNAL 2005;:60-

The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals
Meng Qy, Cheng G, Silver L, Sun Xj, Rehnberg C, Tomson G
HEALTH POLICY AND PLANNING 2005;20(3):185-96

The impact of urban health insurance reform on hospital charges: a case study from two cities in China
Meng Qy, Rehnberg C, Zhuang N, Bian Y, Tomson G, Tang Sl
HEALTH POLICY 2004;68(2):197-209

A description of outpatient drug use in rural China: Evidence of differences due to insurance coverage
Dong Hj, Bogg L, Wang Kl, Rehnberg C, Diwan V
INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT 1999;14(1):41-56

Association between health insurance and antibiotics prescribing in four counties in rural China
Dong Hj, Bogg L, Rehnberg C, Diwan V
HEALTH POLICY 1999;48(1):29-45

Drug policy in China: pharmaceutical distribution in rural areas
Dong Hj, Bogg L, Rehnberg C, Diwan V
SOCIAL SCIENCE & MEDICINE 1999;48(6):777-86

Health financing policies - Providers' opinions and prescribing behavior in rural China
Dong Hj, Bogg L, Rehnberg C, Diwan Cv
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 1999;15(4):686-98

Internal markets and health care efficiency: A multiple-output stochastic frontier analysis
Gerdtham Ug, Lothgren M, Tambour M, Rehnberg C
HEALTH ECONOMICS 1999;8(2):151-64

Pharmaceutical expenditure in Sweden
Henriksson F, Hjortsberg C, Rehnberg C
HEALTH POLICY 1999;47(2):125-44

The impact of internal markets on health care efficiency: evidence from health care reforms in Sweden
Gerdtham Ug, Rehnberg C, Tambour M
APPLIED ECONOMICS 1999;31(8):935-945

Visa alla publikationer